Bayat Allan, Christensen Mette, Wibrand Flemming, Duno Morten, Lund Allan
Department of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark,
JIMD Rep. 2015;18:135-7. doi: 10.1007/8904_2014_368. Epub 2014 Nov 4.
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency results in a continuous spectrum of clinical phenotypes though all include overproduction of uric acid with hyperuricaemia, urate nephrolithiasis and gout. HPRT1 mutations that result in very low or no HPRT enzyme activities are generally associated with the classic Lesch-Nyhan disease (LND) phenotype with intellectual disability, motor handicap and self-injurious behaviour. Mutations that permit a higher residual HPRT activity are seen in some patients with the milder LND variant phenotypes with varying degrees of cognitive, motor handicap and maladaptive behaviour without recurrent self-injury. We present a boy with a LND variant phenotype due to a deletion of exon 5 of HPRT1 predicted to fully abolish HPRT activity. Metabolic analysis confirms lack of significant residual enzyme activity. The boy, currently age 10, presented with hyperuricaemia, hypotonia, developmental delay and extrapyramidal and pyramidal involvement. He has never shown any signs of self-injurious or maladaptive behaviour. This boy is one of the rare cases with a suspected null mutation in HPRT1 that associates with a milder than expected phenotype with lack of self-injurious behaviour. Key Clinical Message HPRT1 mutations that result in very low or no hypoxanthine-guanine phosphoribosyltransferase enzyme activities are generally associated with the classic Lesch-Nyhan disease. This report presents one of the rare cases with a null mutation in the HPRT1 gene that associates with a milder than expected phenotype with lack of self-injurious behaviour.
次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶(HPRT)缺乏会导致一系列连续的临床表型,尽管所有表型都包括尿酸过度生成伴高尿酸血症、尿酸盐肾结石和痛风。导致HPRT酶活性极低或无活性的HPRT1突变通常与经典的莱施 - 奈恩病(LND)表型相关,伴有智力残疾、运动障碍和自伤行为。在一些患有较轻LND变异表型的患者中可观察到允许较高残余HPRT活性的突变,这些患者有不同程度的认知、运动障碍和适应不良行为,但无反复自伤行为。我们报告一名患有LND变异表型的男孩,其HPRT1基因外显子5缺失,预计会完全消除HPRT活性。代谢分析证实缺乏显著的残余酶活性。该男孩目前10岁,表现为高尿酸血症、肌张力减退、发育迟缓以及锥体外系和锥体受累。他从未表现出任何自伤或适应不良行为的迹象。这名男孩是罕见的疑似HPRT1基因无效突变病例之一,该突变与比预期更轻的表型相关且无自伤行为。关键临床信息:导致次黄嘌呤 - 鸟嘌呤磷酸核糖转移酶酶活性极低或无活性的HPRT1突变通常与经典的莱施 - 奈恩病相关。本报告展示了HPRT1基因无效突变的罕见病例之一,该突变与比预期更轻且无自伤行为的表型相关。